HY-124416-100mg
|
MedChemexpress LLC
|
ML604086 [CAS 850330-18-6]
|
|
COVID-19-immunoregulation
|
|
HY-124416-25mg
|
MedChemexpress LLC
|
ML604086 [CAS 850330-18-6]
|
|
COVID-19-immunoregulation
|
|
HY-124416-5mg
|
MedChemexpress LLC
|
ML604086 [CAS 850330-18-6]
|
|
COVID-19-immunoregulation
|
|
HY-124416-50mg
|
MedChemexpress LLC
|
ML604086 [CAS 850330-18-6]
|
|
COVID-19-immunoregulation
|
|
HY-124416-1mL
|
MedChemexpress LLC
|
ML604086 [CAS 850330-18-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-N0502-10mg
|
MedChemexpress LLC
|
Mogroside V [CAS 88901-36-4]
|
|
Cancer-programmed cell death
|
|
HY-N0502-5mg
|
MedChemexpress LLC
|
Mogroside V [CAS 88901-36-4]
|
|
Cancer-programmed cell death
|
|
HY-N0502-50mg
|
MedChemexpress LLC
|
Mogroside V [CAS 88901-36-4]
|
|
Cancer-programmed cell death
|
|
HY-N0502-1mL
|
MedChemexpress LLC
|
Mogroside V [CAS 88901-36-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-N0316-1mg
|
MedChemexpress LLC
|
Mollugin [CAS 55481-88-4]
|
|
Cancer-programmed cell death
|
|
HY-N0316-10mg
|
MedChemexpress LLC
|
Mollugin [CAS 55481-88-4]
|
|
Cancer-programmed cell death
|
|
HY-N0316-20mg
|
MedChemexpress LLC
|
Mollugin [CAS 55481-88-4]
|
|
Cancer-programmed cell death
|
|
HY-N0316-5mg
|
MedChemexpress LLC
|
Mollugin [CAS 55481-88-4]
|
|
Cancer-programmed cell death
|
|